Quick Answer
FATE THERAPEUTICS INC reported Common Stock Shares Outstanding of 115.36 million shares for the year ending 2025.
- FATE THERAPEUTICS INC showed an increase of +1.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: 1.38 million shares | Q1 2014: 20.46 million shares | Q2 2014: 20.56 million shares | Q3 2014: 20.56 million shares | Q1 2015: 20.64 million shares | Q2 2015: 28.62 million shares | Q3 2015: 28.72 million shares | Q1 2016: 28.86 million shares | Q2 2016: 28.88 million shares | Q3 2016: 34.15 million shares | Q1 2017: 41.40 million shares | Q2 2017: 41.42 million shares | Q3 2017: 41.46 million shares | Q1 2018: 52.86 million shares | Q2 2018: 53.39 million shares | Q3 2018: 64.50 million shares | Q1 2019: 65.12 million shares | Q2 2019: 65.31 million shares | Q3 2019: 75.42 million shares | Q1 2020: 76.00 million shares | Q2 2020: 86.80 million shares | Q3 2020: 87.00 million shares | Q1 2021: 93.89 million shares | Q2 2021: 94.27 million shares | Q3 2021: 95.36 million shares | Q1 2022: 96.54 million shares | Q2 2022: 96.86 million shares | Q3 2022: 97.11 million shares | Q1 2023: 98.19 million shares | Q2 2023: 98.52 million shares | Q3 2023: 98.59 million shares | Q1 2024: 113.80 million shares | Q2 2024: 113.85 million shares | Q3 2024: 113.88 million shares | Q1 2025: 114.60 million shares | Q2 2025: 114.66 million shares | Q3 2025: 115.34 million shares.
- Over the full 14 years of available data (2012 to 2025), FATE THERAPEUTICS INC's Common Stock Shares Outstanding has grown by 8,546.9%.
- Historical annual values: Fiscal year 2025: 115.36 million shares | Fiscal year 2024: 113.93 million shares | Fiscal year 2023: 98.63 million shares | Fiscal year 2022: 97.29 million shares | Fiscal year 2021: 95.73 million shares | Fiscal year 2020: 87.72 million shares | Fiscal year 2019: 75.73 million shares | Fiscal year 2018: 64.69 million shares | Fiscal year 2017: 52.65 million shares | Fiscal year 2016: 41.39 million shares | Fiscal year 2015: 28.72 million shares | Fiscal year 2014: 20.57 million shares | Fiscal year 2013: 20.43 million shares | Fiscal year 2012: 1.33 million shares.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: